Given that the research team seems to be a clinical based team in the United Kingdom, it's possible that some may have been drafted into the COVID-19 response. This may explain the delay of the results which was initially set for late Q1/early Q2.
If this Phase 2 doesn't deliver, I expect the SP to tank.
Ann: Investor Presentation, page-45
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
